Constanza Salas-Ramos
Senior Strategic Advisor – Health Policy, Market Access & HEOR
Executive Summary
Constanza Salas-Ramos is a Market Access, Health Policy, and HEOR leader with over eight years of experience across the pharmaceutical industry, public sector, and international organizations. She specializes in designing and implementing evidence-based access strategies that integrate clinical, epidemiological, and economic insights to inform reimbursement and policy decision-making.
Her career combines senior leadership in government—including heading national HTA and evidence-based health functions at Chile’s Ministry of Health—with hands-on experience in industry and global consulting. She brings a unique ability to connect technical rigor with real-world payer and policy dynamics, supporting sustainable access to high-value health technologies.
Thera Contribution
At Thera, Constanza contributes to strengthening the firm’s evidence-driven advisory capabilities through:
- Design of market access and value strategies grounded in HTA and HEOR
- Development of payer-relevant evidence frameworks (CEA, BIA, RWE)
- Strategic advisory on pricing, reimbursement, and coverage pathways
- Engagement with health authorities, payers, and key stakeholders
- Translation of complex evidence into actionable policy and commercial insights
Her profile enhances Thera’s ability to integrate policy, evidence generation, and access execution across Latin America.
Executive Profile
Constanza is an evidence-driven advisor recognized for bridging technical analysis with strategic decision-making in health systems. She has led multidisciplinary teams, advised senior policymakers, and contributed to the prioritization and reimbursement of high-cost and innovative therapies.
Her approach combines analytical depth with stakeholder engagement, positioning her at the intersection of science, policy, and market access.
Her leadership is defined by a 360-degree evidence-based perspective, combining:
- Advanced expertise in HEOR, HTA, and economic evaluation methodologies
- Deep understanding of payer decision-making and health system constraints
- Alignment of clinical value, economic sustainability, and policy priorities
- Strong engagement with health authorities, payers, and academic stakeholders
- Ability to translate complex data into clear, policy-relevant insights
Areas of Strategic Impact
- Health Economics & Outcomes Research (HEOR)
- Health Technology Assessment (HTA) frameworks and evidence generation
- Pricing, reimbursement, and value-based healthcare strategies
- Real-world evidence (RWE) and economic modeling (CEA, BIA)
- Market access strategy and execution
- Public policy and coverage prioritization
- Stakeholder engagement across public and private sectors
Professional Background
Her most recent roles include:
Head of Health Technology Assessment (HTA) and Evidence-Based Health – Ministry of Health, Chile
Leading national HTA and evidence-generation activities to support reimbursement and coverage decisions for high-cost and innovative therapies, while advising senior government leadership.
Senior Market Access Manager – Teva Pharmaceuticals (Latin America)
Leading market access strategies across the region, aligning clinical and economic evidence with payer requirements and supporting reimbursement processes across multiple markets.
Senior Analyst – Research Partnership (UK)
Supporting global HEOR and market access projects, including evidence synthesis and development of payer-focused value communication strategies.
Earlier in her career, she contributed to:
- OECD (France) – international health policy research and global reports
- Bayer (Chile) – market access and public procurement engagement
Professional Impact & Leadership
Throughout her career, Constanza has:
- Led HTA and HEOR initiatives informing reimbursement and coverage decisions
- Advised policymakers on prioritization of high-cost and innovative technologies
- Developed economic models and payer-relevant evidence frameworks
- Strengthened evidence-based decision-making systems in public and private settings
- Contributed to international policy and research initiatives
Her work consistently ensures that evidence translates into access, policy impact, and system-level value.
Academic & Professional Credentials
- MSc in International Health Policy (Health Economics), London School of Economics (LSE)
- Pharmacist, University of Chile
Additional Programs:
- Microsimulation and cost-effectiveness – Stanford University
- HTA dossier development – University of York
